Cancer
-
Celebrating over 100 years of innovation
Posted on:
The inaugural Eva Kolling Research Day was staged within Royal North Shore Hospital, providing the perfect chance to celebrate the vision and generosity of a true pioneer. Established in 1920, the Kolling Institute is the oldest medical research institute in New South Wales. It has been at the forefront of cutting-edge research for more than…
-
Improving cancer detection in young people with neurofibromatosis type 1
Posted on:
Researchers from Royal North Shore Hospital and the Kolling Institute will lead Australia’s first study of whole-body screening for young people with neurofibromatosis type 1. Led by Dr Sue-Faye Siow from the department of clinical genetics, the study was awarded a grant through the RNSH Campus Research Grants Scheme, and an additional $30,000 in support…
-
-
Multi-million dollar grant to improve treatment for lung cancer
Posted on:
Leading Royal North Shore Hospital clinician researcher Professor Nick Pavlakis and Professor Ben Solomon have secured a $14.7 million MRFF grant for a clinical trial which will explore the use of a liquid biopsy to inform treatment for lung cancer. The condition is the leading cause of cancer death in Australia and worldwide, claiming an…
-
Prestigious grant for groundbreaking blood cancer research at the Kolling
Posted on:
A two-decade long commitment to reducing blood cancers has delivered coveted national funding to Associate Professor Jenny Wang to progress her vital cancer research. As the head of the Kolling Institute’s Cancer and Stem Cell Laboratory, Associate Professor Wang has secured a $2.95 million investigator grant from the National Health and Medical Research Council to…
-
Cancer experts going from strength to strength
Posted on:
A special visit by two international cancer specialists could mark the start of a valuable collaborative partnership. Professor Matthew Katz from the MD Anderson Cancer Centre in Houston Texas is recognised as a pioneer in the treatment of pancreatic cancer, while Professor Cynthia Sears from the Johns Hopkins University School of Medicine in Baltimore is…
-
Partnership to drive innovation in genomic science
Posted on:
An exciting partnership between AGRF Ltd (Australian Genome Research Facility) and the University of Sydney and the Kolling Institute will help strengthen genomic capabilities. The partnership will see a specialised team and cutting-edge technology located within the institute to progress research in this increasingly crucial field. As Australia’s largest provider of genomic services, AGRF supports…
-
Kolling Research Symposium 2024
Posted on:
We would like to thank everyone involved in the 2024 Kolling Institute Symposium. During the event, a diverse collection of researchers detailed the latest progress with their ground-breaking work into kidney and heart disease treatments, bone and muscle conditions, rare cancers, and neurological challenges. There was a focus too on the innovative work to develop…
-
Kolling NEWS
Posted on:
Our Kolling Institute newsletter brings together a collection of profiles on our impressive researchers. Flip through our flipping book to discover more about our leading research into kidney disease, rare cancers and the use of supplements for osteoarthritis. There’s a focus too on the first steps towards gene therapy for Meniere’s disease, the latest research into treatments for…
-
Spotlight on clinical trials
Posted on:
Kolling Institute researcher and Royal North Shore Hospital endocrinologist Professor Rory Clifton-Bligh has been involved in clinical trials for more than 20 years, focusing on conditions such as osteoporosis, thyroid cancer and diabetes. Patients in the endocrinology clinic have sometimes accessed medication 10 years ahead of other Australians. Many of these drugs have gone on…
Copyright © 2026 Kolling Institute
All rights reserved